<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhang P</submitter><funding>Science and Technology Program of Guizhou Province</funding><pagination>e0305343</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11226129</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>19(7)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Salidroside (SAL), the main component of Rhodiola rosea extract, is a flavonoid with biological activities, such as antioxidative stress, anti-inflammatory, and hypolipidemic. In this study, the potential therapeutic targets and mechanisms of SAL against oxidative stress in retinal ganglion cells (RGCs) were investigated on the basis of in-vitro experiments, network pharmacology, and molecular docking techniques.&lt;h4>Methods&lt;/h4>RGC oxidative stress models were constructed, and cell activity, reactive oxygen species (ROS), and apoptosis levels were examined for differences. The genes corresponding to rhodopsin, RGCs, and oxidative stress were screened from GeneCards, TCMSP database, and an analysis platform. The intersection of the three was taken, and a Venn diagram was </pubmed_abstract><journal>PloS one</journal><pubmed_title>Network pharmacology and molecular-docking-based strategy to explore the potential mechanism of salidroside-inhibited oxidative stress in retinal ganglion cell.</pubmed_title><pmcid>PMC11226129</pmcid><funding_grant_id>[ZK[2021]YB473]</funding_grant_id><pubmed_authors>Xia X</pubmed_authors><pubmed_authors>You Z</pubmed_authors><pubmed_authors>Xiao H</pubmed_authors><pubmed_authors>Cao F</pubmed_authors><pubmed_authors>Han C</pubmed_authors><pubmed_authors>Wang J</pubmed_authors><pubmed_authors>Zhang P</pubmed_authors><pubmed_authors>Zhao H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Network pharmacology and molecular-docking-based strategy to explore the potential mechanism of salidroside-inhibited oxidative stress in retinal ganglion cell.</name><description>&lt;h4>Background&lt;/h4>Salidroside (SAL), the main component of Rhodiola rosea extract, is a flavonoid with biological activities, such as antioxidative stress, anti-inflammatory, and hypolipidemic. In this study, the potential therapeutic targets and mechanisms of SAL against oxidative stress in retinal ganglion cells (RGCs) were investigated on the basis of in-vitro experiments, network pharmacology, and molecular docking techniques.&lt;h4>Methods&lt;/h4>RGC oxidative stress models were constructed, and cell activity, reactive oxygen species (ROS), and apoptosis levels were examined for differences. The genes corresponding to rhodopsin, RGCs, and oxidative stress were screened from GeneCards, TCMSP database, and an analysis platform. The intersection of the three was taken, and a Venn diagram was </description><dates><release>2024-01-01T00:00:00Z</release><publication>2024</publication><modification>2025-04-04T23:54:53.368Z</modification><creation>2025-04-04T23:54:53.368Z</creation></dates><accession>S-EPMC11226129</accession><cross_references><pubmed>38968273</pubmed><doi>10.1371/journal.pone.0305343</doi></cross_references></HashMap>